EUVIMEDEUVIMED entdecken
Crossref

Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression

Amirhossein Molaei, Farzaneh Kermani, Pouya Goleij

The Nucleus · 09.07.2026

DOI: 10.1007/s13237-026-00693-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Nucleus, online erschienen am 09.07.2026. Verfasst von Amirhossein Molaei und 2 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Molaei, A., Kermani, F., & Goleij, P. (2026). Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression. The Nucleus. https://doi.org/10.1007/s13237-026-00693-z

Vancouver

Molaei A, Kermani F, Goleij P. Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression. The Nucleus. 2026. doi:10.1007/s13237-026-00693-z

BibTeX
@article{Molaei2026,
  author = {Molaei, Amirhossein and Kermani, Farzaneh and Goleij, Pouya},
  title = {Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression},
  journal = {The Nucleus},
  year = {2026},
  doi = {10.1007/s13237-026-00693-z}
}
Kostenlos starten →